Confidence: 95%
B0G5QQFMG2
View on Amazon →Decision summary
A solid product, but not a clean win. The main trade-off is weaker ingredient form quality.
Best for
People prioritizing high absorption and overall formula quality.
Consider another option if
You prefer fully transparent formulas over blends and ambiguous labeling.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
8.2/10Generally solid dosing
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
Dose 8.2/10 · Bioavailability 5.2/10 · Coherence 6/10
A proprietary blend limits independent dose verification.
This is a multi-ingredient product. The score reflects formulation quality, not efficacy for a specific health goal.
Chromium: high-bioavailability form declared (Chromium Picolinate). The main limitation is that proprietary blend prevents independent dose verification.
Strengths
Weaknesses
Final verdict
A solid product, but not a clean win. The main trade-off is weaker ingredient form quality.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
✔ Clinically effective dose with moderate supporting evidence
A clear strength: Dose is strong and within effective ranges. The declared form supports strong absorption.
Scientific evidence
Balk et al. systematic review chromium picolinate and glycemic control
Diabetes Technology & Therapeutics • 2007
PMID: 17519436.0
ℹ Dose is below the optimal range with moderate supporting evidence
Strong contributor: Dose is strong and within effective ranges.
Scientific evidence
Patel et al. systematic review biotin and hair/nail health
Skin Appendage Disorders • 2017
PMID: 28786550.0
⚠ Limited evidence exists, and dose is below effective threshold
This is a limiting factor: Dose is likely below clinically useful levels.
Scientific evidence
Fuangchan et al. meta-analysis bitter melon and type 2 diabetes
Journal of Ethnopharmacology • 2011
PMID: 23777923.0
Evidence inferred from established knowledge, not directly linked studies
Supports the formula, but not a major driver: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Evidence inferred from established knowledge, not directly linked studies
Solid but not a standout: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Proprietary blend limits dose transparency
Exact ingredient amounts cannot be verified clearly.
Formula design looks less coherent than stronger alternatives
The formulation appears less focused than better-built options.
Bitter Melon dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Berberine supplements ranked with the same methodology, or keep exploring the database.
